A new role for T cells in dampening innate inflammatory responses (original) (raw)
References
Medzhitov R. Origin and physiological roles of inflammation. Nature, 2008, 454: 428–435 10.1038/nature07201, 1:CAS:528:DC%2BD1cXovV2mtbw%3D, 18650913 ArticlePubMedCAS Google Scholar
Medzhitov R. Approaching the asymptote: 20 years later. Immunity, 2009, 30: 766–775 10.1016/j.immuni.2009.06.004, 1:CAS:528:DC%2BD1MXpsFCntbk%3D, 19538928 ArticlePubMedCAS Google Scholar
Zhao J, Yang X, Auh S L, et al. Do adaptive immune cells suppress or activate innate immunity? Trends Immunol, 2009, 30: 8–12 10.1016/j.it.2008.10.003, 19058755 ArticlePubMed Google Scholar
Cavaillon J M, Annane D. Compartmentalization of the inflammatory response in sepsis and SIRS. J Endotoxin Res, 2006, 12: 151–170 10.1179/096805106X102246, 1:CAS:528:DC%2BD28XmtV2hs7g%3D, 16719987 ArticlePubMedCAS Google Scholar
Brooks D G, Trifilo M J, Edelmann K H, et al. Interleukin-10 determines viral clearance or persistence in vivo. Nat Med, 2006, 12: 1301–1309 10.1038/nm1492, 1:CAS:528:DC%2BD28XhtFKlsLfO, 17041596 ArticlePubMedCASPubMed Central Google Scholar
Sharpe A H, Wherry E J, Ahmed R, et al. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol, 2007, 8: 239–245 10.1038/ni1443, 1:CAS:528:DC%2BD2sXhslWms78%3D, 17304234 ArticlePubMedCAS Google Scholar
Akira S, Takeda K, Kaisho T. Toll-like receptors: Critical proteins linking innate and acquired immunity. Nat Immunol, 2001, 2: 675–680 10.1038/90609, 1:CAS:528:DC%2BD3MXlslGjtLs%3D, 11477402 ArticlePubMedCAS Google Scholar
Janeway C A J, Medzhitov R. Innate immune recognition. Annu Rev Immunol, 2002, 20: 197–216 10.1146/annurev.immunol.20.083001.084359, 1:CAS:528:DC%2BD38XjtlWgt7Y%3D, 11861602 ArticlePubMedCAS Google Scholar
Takeuchi O, Akira S. Innate immunity to virus infection. Immunol Rev, 2009, 227: 75–86 10.1111/j.1600-065X.2008.00737.x, 1:CAS:528:DC%2BD1MXhsFGls7zI, 19120477 ArticlePubMedCAS Google Scholar
Takaoka A, Wang Z, Choi M K, et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature, 2007, 448: 501–505 10.1038/nature06013, 1:CAS:528:DC%2BD2sXotFajurk%3D, 17618271 ArticlePubMedCAS Google Scholar
Schroder K, Muruve D A, Tschopp J. Innate immunity: Cytoplasmic DNA sensing by the AIM2 inflammasome. Curr Biol, 2009, 19: R262–265 10.1016/j.cub.2009.02.011, 1:CAS:528:DC%2BD1MXjsFWru7Y%3D, 19321146 ArticlePubMedCAS Google Scholar
Sabbah A, Chang T H, Harnack R, et al. Activation of innate immune antiviral responses by Nod2. Nat Immunol, 2009, 10: 1073–1080 10.1038/ni.1782, 1:CAS:528:DC%2BD1MXhtVaksrrP, 19701189 ArticlePubMedCASPubMed Central Google Scholar
O’Neill L A. DNA makes RNA makes innate immunity. Cell, 2009, 138: 428–430 10.1016/j.cell.2009.07.021, 19665965 ArticlePubMed Google Scholar
Medzhitov R, Janeway C A J. Innate immunity: The virtues of a nonclonal system of recognition. Cell, 1997, 91: 295–298 10.1016/S0092-8674(00)80412-2, 1:CAS:528:DyaK2sXnt1Clsrw%3D, 9363937 ArticlePubMedCAS Google Scholar
Stout R D, Bottomly K. Antigen-specific activation of effector macrophages by IFN-gamma producing (TH1) T cell clones. Failure of IL-4-producing (TH2) T cell clones to activate effector function in macrophages. J Immunol, 1989, 142: 760–765 1:CAS:528:DyaL1MXhtFartbY%3D, 2464024 PubMedCAS Google Scholar
Monney L, Sabatos C A, Gaglia J L, et al. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature, 2002, 415: 536–541 10.1038/415536a, 1:CAS:528:DC%2BD38Xht1GhtLs%3D, 11823861 ArticlePubMedCAS Google Scholar
Duffield J S. The inflammatory macrophage: A story of Jekyll and Hyde. Clin Sci (Lond) 2003, 104: 27–38 10.1042/CS20020240, 1:CAS:528:DC%2BD3sXitVOqtQ%3D%3D ArticleCAS Google Scholar
Foster P S, Hogan S P, Ramsay A J, et al. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med, 1996, 183: 195–201 10.1084/jem.183.1.195, 1:CAS:528:DyaK28XjsVCgtQ%3D%3D, 8551223 ArticlePubMedCAS Google Scholar
Iwamoto I, Nakajima H, Endo H, et al. Interferon gamma regulates antigen-induced eosinophil recruitment into the mouse airways by inhibiting the infiltration of CD4+ T cells. J Exp Med, 1993, 177: 573–576 10.1084/jem.177.2.573, 1:CAS:528:DyaK3sXnvFamsw%3D%3D, 8093895 ArticlePubMedCAS Google Scholar
Ohnishi T, Kita H, Weiler D, et al. IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late-phase reaction. Am Rev Respir Dis, 1993, 147: 901–907 1:CAS:528:DyaK3sXisFeitLc%3D, 8466126 ArticlePubMedCAS Google Scholar
Beaven M A, Metzger H. Signal transduction by Fc receptors: The Fc epsilon RI case. Immunol Today, 1993, 14: 222–226 10.1016/0167-5699(93)90167-J, 1:CAS:528:DyaK3sXltlKru7g%3D, 8517921 ArticlePubMedCAS Google Scholar
Cooper N R. The classical complement pathway: Activation and regulation of the first complement component. Adv Immunol, 1985, 37: 151–216 10.1016/S0065-2776(08)60340-5, 1:CAS:528:DyaL2MXksFagsro%3D, 3890478 ArticlePubMedCAS Google Scholar
Kalesnikoff J, Huber M, Lam V, et al. Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival. Immunity, 2001, 14: 801–811 10.1016/S1074-7613(01)00159-5, 1:CAS:528:DC%2BD3MXkvFSlt7g%3D, 11420049 ArticlePubMedCAS Google Scholar
Leibson P J. Signal transduction during natural killer cell activation: Inside the mind of a killer. Immunity, 1997, 6: 655–661 10.1016/S1074-7613(00)80441-0, 1:CAS:528:DyaK2sXktFCqs7Y%3D, 9208838 ArticlePubMedCAS Google Scholar
Takai T. Multiple loss of effector cell functions in FcR gammadeficient mice. Int Rev Immunol, 1996, 13: 369–381 10.3109/08830189609061759, 1:CAS:528:DyaK28XmtFChu70%3D, 8884432 ArticlePubMedCAS Google Scholar
Kim K D, Zhao J, Yang X, et al. Adaptive immune cells temper initial innate responses. Nat Med, 2007, 13: 1248–1252 10.1038/nm1207-1409, 1:CAS:528:DC%2BD2sXhtFagsbrN, 17891146 ArticlePubMedCASPubMed Central Google Scholar
Kim K D, Zhao J, Auh S, et al. Adaptive immune cells temper initial innate responses. Nat Med, 2007, 13: 1248–1252 10.1038/nm1207-1409, 1:CAS:528:DC%2BD2sXhtFagsbrN, 17891146 ArticlePubMedCASPubMed Central Google Scholar
Maloy K J, Salaun L, Cahill R, et al. CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med, 2003, 197: 111–119 10.1084/jem.20021345, 1:CAS:528:DC%2BD3sXjslWltg%3D%3D, 12515818 ArticlePubMedCASPubMed Central Google Scholar
Smyth M J, Teng M W, Swann J, et al. CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer. J Immunol, 2006, 176: 1582–1587 1:CAS:528:DC%2BD28XlsFynsw%3D%3D, 16424187 ArticlePubMedCAS Google Scholar
Tiemessen M M, Jagger A L, Evans H G, et al. CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages. Proc Natl Acad Sci USA, 2007, 104: 19446–19451 10.1073/pnas.0706832104, 1:CAS:528:DC%2BD1cXisVOhsA%3D%3D, 18042719 ArticlePubMedCASPubMed Central Google Scholar
Garrett W S, Lord G M, Punit S, et al. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell, 2007, 131: 33–45 10.1016/j.cell.2007.08.017, 1:CAS:528:DC%2BD2sXht1CntLjF, 17923086 ArticlePubMedCASPubMed Central Google Scholar
Miyara M, Sakaguchi S. Natural regulatory T cells: Mechanisms of suppression. Trends Mol Med, 2007, 13: 108–116 10.1016/j.molmed.2007.01.003, 1:CAS:528:DC%2BD2sXisl2kurg%3D, 17257897 ArticlePubMedCAS Google Scholar
Lund J M, Hsing L, Pham T T, et al. Coordination of early protective immunity to viral infection by regulatory T cells. Science, 2008, 320: 1220–1224 10.1126/science.1155209, 1:CAS:528:DC%2BD1cXmt1Oisrk%3D, 18436744 ArticlePubMedCASPubMed Central Google Scholar
Zhang X, Deriaud E, Jiao X, et al. Type I interferons protect neonates from acute inflammation through interleukin 10-producing B cells. J Exp Med, 2007, 204: 1107–1118 10.1084/jem.20062013, 1:CAS:528:DC%2BD2sXlsFSjtrg%3D, 17485512 ArticlePubMedCASPubMed Central Google Scholar
Zhao J, Kim K D, Yang X, et al. Hyper innate responses in neonates lead to increased morbidity and mortality after infection. Proc Natl Acad Sci USA, 2008, 105: 7528–7533 10.1073/pnas.0800152105, 1:CAS:528:DC%2BD1cXmvFGjurY%3D, 18490660 ArticlePubMedCASPubMed Central Google Scholar
Adkins B, Leclerc C, Marshall-Clarke S. Neonatal adaptive immunity comes of age. Nat Rev Immunol, 2004, 4: 553–564 10.1038/nri1394, 1:CAS:528:DC%2BD2cXlt1Cqurg%3D, 15229474 ArticlePubMedCAS Google Scholar
Levy O. Innate immunity of the newborn: Basic mechanisms and clinical correlates. Nat Rev Immunol, 2007, 7: 379–390 10.1038/nri2075, 1:CAS:528:DC%2BD2sXksFeks7w%3D, 17457344 ArticlePubMedCAS Google Scholar
Chen L. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat Rev Immunol, 2004, 4: 336–347 10.1038/nri1349, 1:CAS:528:DC%2BD2cXjsFChsrY%3D, 15122199 ArticlePubMedCAS Google Scholar
Sun Y, Brown N K, Ruddy M J, et al. B and T lymphocyte attenuator tempers early infection immunity. J Immunol, 2009, 183: 1946–1951 10.4049/jimmunol.0801866, 1:CAS:528:DC%2BD1MXoslCrsL0%3D, 19587015 ArticlePubMedCASPubMed Central Google Scholar
Franchi L, Eigenbrod T, Munoz-Planillo R, et al. The inflammasome: A caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol, 2009, 10: 241–247 10.1038/ni.1703, 1:CAS:528:DC%2BD1MXhvFKjtLo%3D, 19221555 ArticlePubMedCASPubMed Central Google Scholar
Martinon F, Mayor A, Tschopp J. The inflammasomes: Guardians of the body. Annu Rev Immunol, 2009, 27: 229–265 10.1146/annurev.immunol.021908.132715, 1:CAS:528:DC%2BD1MXlsFSlsbc%3D, 19302040 ArticlePubMedCAS Google Scholar
Ogura Y, Sutterwala F S, Flavell R A. The inflammasome: First line of the immune response to cell stress. Cell, 2006, 126: 659–662 10.1016/j.cell.2006.08.002, 1:CAS:528:DC%2BD28Xpt1aktbo%3D, 16923387 ArticlePubMedCAS Google Scholar
Tschopp J, Martinon F, Burns K. NALPs: A novel protein family involved in inflammation. Nat Rev Mol Cell Biol, 2003, 4: 95–104 10.1038/nrm1019, 1:CAS:528:DC%2BD3sXnsFaquw%3D%3D, 12563287 ArticlePubMedCAS Google Scholar
Church L D, Cook G P, McDermott M F. Primer: Inflammasomes and interleukin 1beta in inflammatory disorders. Nat Clin Pract Rheumatol, 2008, 4: 34–42 10.1038/ncprheum0681, 1:CAS:528:DC%2BD1cXhtlKjtQ%3D%3D, 18172447 ArticlePubMedCAS Google Scholar
McDermott M F, Tschopp J. From inflammasomes to fevers, crystals and hypertension: How basic research explains inflammatory diseases. Trends Mol Med, 2007, 13: 381–388 10.1016/j.molmed.2007.07.005, 1:CAS:528:DC%2BD2sXhtVCnsrnM, 17822957 ArticlePubMedCAS Google Scholar
Guarda G, Dostert C, Staehli F, et al. T cells dampen innate immune responses through inhibition of NLRP1 and NLRP3 inflammasomes. Nature, 2009, 460: 269–273 10.1038/nature08100, 1:CAS:528:DC%2BD1MXmslCmtrs%3D, 19494813 ArticlePubMedCAS Google Scholar
O’sullivan B, Thomas R. CD40 and dendritic cell function. Crit Rev Immunol, 2003, 23: 83–107 10.1615/CritRevImmunol.v23.i12.50, 12906261 ArticlePubMed Google Scholar
Litman G W, Cannon J P, Dishaw L J. Reconstructing immune phylogeny: new perspectives. Nat Rev Immunol, 2005, 5: 866–879 10.1038/nri1712, 1:CAS:528:DC%2BD2MXhtFKls7jI, 16261174 ArticlePubMedCASPubMed Central Google Scholar
Aggarwal K, Silverman N. Positive and negative regulation of the Drosophila immune response. BMB Rep, 2008, 41: 267–277 1:CAS:528:DC%2BD1cXlvFelsLw%3D, 18452646 ArticlePubMedCAS Google Scholar
Liew F Y, Xu D, Brint E K, et al. Negative regulation of toll-like receptor mediated immune responses. Nat Rev Immunol, 2005, 5: 446–458 10.1038/nri1630, 1:CAS:528:DC%2BD2MXks1GmsLo%3D, 15928677 ArticlePubMedCAS Google Scholar
Thomas R M, Linch D C. Identification of lymphocyte subsets in the newborn using a variety of monoclonal antibodies. Arch Dis Child, 1983, 58: 34–38 10.1136/adc.58.1.34, 1:STN:280:DyaL3s7ltFKhsA%3D%3D, 6219626 ArticlePubMedCASPubMed Central Google Scholar
Heldrup J, Kalm O, Prellner K. Blood T and B lymphocyte subpopulations in healthy infants and children. Acta Paediatr, 1992, 81: 125–132 10.1111/j.1651-2227.1992.tb12187.x, 1:STN:280:DyaK38zos1Sjtg%3D%3D, 1515755 ArticlePubMedCAS Google Scholar
Kumar A, Jauhari P, Singh U, et al. Quantitation of T cells in venous blood of healthy neonates. Indian J Pediatr, 1994, 61: 711–714 10.1007/BF02751986, 1:STN:280:DyaK2M3jsl2htg%3D%3D, 7721377 ArticlePubMedCAS Google Scholar
Atici A, Satar M, Cetíner S, et al. Serum tumor necrosis factor-alpha in neonatal sepsis. Am J Perinatol, 1997, 14: 401–404 10.1055/s-2007-994168, 1:STN:280:DyaK2svgvFWntA%3D%3D, 9263559 ArticlePubMedCAS Google Scholar
Blackwell C C, Moscovis S M, Gordon A E, et al. Cytokine responses and sudden infant death syndrome: Genetic, developmental, and environmental risk factors. J Leukoc Biol, 2005, 78: 1242–1254 10.1189/jlb.0505253, 1:CAS:528:DC%2BD2MXhtleksLrI, 16204631 ArticlePubMedCAS Google Scholar
Ozdemir A, Oygür N, Gültekin M, et al. Neonatal tumor necrosis factor, interleukin-1 alpha, interleukin-1 beta, and interleukin-6 response to infection. Am J Perinatol, 1994, 11: 282–285 10.1055/s-2007-994592, 1:STN:280:DyaK2M%2Fjt1ektw%3D%3D, 7945622 ArticlePubMedCAS Google Scholar
Vege A, Rognum T O, Aasen A O, et al. Are elevated cerebrospinal fluid levels of IL-6 in sudden unexplained deaths, infectious deaths and deaths due to heart/lung disease in infants and children due to hypoxia? Acta Paediatr, 1998, 87: 819–824 10.1080/080352598750013563, 1:STN:280:DyaK1cvgsFKgtg%3D%3D, 9736227 ArticlePubMedCAS Google Scholar
Vege A, Rognum T O, Scott H, et al. SIDS cases have increased levels of interleukin-6 in cerebrospinal fluid. Acta Paediatr, 1995, 84: 193–196 10.1111/j.1651-2227.1995.tb13608.x, 1:STN:280:DyaK2M3ns1Cgtw%3D%3D, 7756807 ArticlePubMedCAS Google Scholar
Palm N W, Medzhitov, R. Not so fast: Adaptive suppression of innate immunity. Nat Med, 2007, 13: 1142–1144 10.1038/nm1007-1142b, 1:CAS:528:DC%2BD2sXhtFagsbrF, 17917657 ArticlePubMedCAS Google Scholar